Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/43540

Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial
Fernández Serrano, Silvia; Dorca i Sargatal, Jordi; Garcia Vidal, Carolina; Fernández Sabé, Núria; Carratalà, Jordi; Fernández-Agüera, Ana; Corominas Sánchez, Mercè; Padrones, Susana; Gudiol i Munté, Francesc; Manresa, Federico
Universitat de Barcelona
Introduction The benefit of corticosteroids as adjunctive treatment in patients with severe community-acquired pneumonia (CAP) requiring hospital admission remains unclear. This study aimed to evaluate the impact of corticosteroid treatment on outcomes in patients with CAP. Methods This was a prospective, double-blind and randomized study. All patients received treatment with ceftriaxone plus levofloxacin and methyl-prednisolone (MPDN) administered randomly and blindly as an initial bolus, followed by a tapering regimen, or placebo. Results Of the 56 patients included in the study, 28 (50%) were treated with concomitant corticosteroids. Patients included in the MPDN group show a more favourable evolution of the pO2/FiO2 ratio and faster decrease of fever, as well as greater radiological improvement at seven days. The time to resolution of morbidity was also significantly shorter in this group. Six patients met the criteria for mechanical ventilation (MV): five in the placebo group (22.7%) and one in the MPDN group (4.3%). The duration of MV was 13 days (interquartile range 7 to 26 days) for the placebo group and three days for the only case in the MPDN group. The differences did not reach statistical significance. Interleukin (IL)-6 and C-reactive protein (CRP) showed a significantly quicker decrease after 24 h of treatment among patients treated with MPDN. No differences in mortality were found among groups. Conclusions MPDN treatment, in combination with antibiotics, improves respiratory failure and accelerates the timing of clinical resolution of severe CAP needing hospital admission.
Corticosteroides
Pneumònia adquirida a la comunitat
Assaigs clínics
Adrenocortical hormones
Community-acquired pneumonia
Clinical trials
cc-by (c) Fernández Serrano, Silvia et al., 2011
http://creativecommons.org/licenses/by/3.0/es
Artículo
info:eu-repo/semantics/publishedVersion
BioMed Central
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Garcia Vidal, Carolina; Labori, Maria; Viasus, Diego; Simonetti, Antonella; Garcia Somoza, Dolors; Dorca i Sargatal, Jordi; Gudiol i Munté, Francesc; Carratalà, Jordi
Rosón, Beatriz; Carratalà, Jordi; Tubau, F.; Dorca i Sargatal, Jordi; Liñares Louzao, Josefina; Pallarés Giner, Roman; Manresa, Federico; Gudiol i Munté, Francesc
Rosón, Beatriz; Carratalà, Jordi; Tubau, Fe; Dorca i Sargatal, Jordi; Liñares Louzao, Josefina; Pallarés Giner, Roman; Manresa, Federico; Gudiol i Munté, Francesc
Rosón, Beatriz; Carratalà, Jordi; Tubau, Fe; Dorca i Sargatal, Jordi; Liñares Louzao, Josefina; Pallarés Giner, Roman; Manresa, Federico; Gudiol i Munté, Francesc
Adamuz, Jordi; Viasus, Diego; Simonetti, Antonella; Jiménez Martínez, Emilio; Molero, Lorena; González Samartino, Maribel; Castillo, Elena; Juvé Udina, Eulàlia; Alcocer, María-Jesús; Hernández Carme; Buera, María Pilar; Roel Fernández, Asunción; Abad, Emilia; Zabalegui Yárnoz, Adelaida; Ricart, Pilar; González, Anna; Isla Pera, Ma. Pilar (María Pilar); Dorca i Sargatal, Jordi; Garcia Vidal, Carolina; Carratalà, Jordi